从医疗机构进药看新型农村合作医疗基本药物目录的实施  

Analysis on the Implementation of National Essential Drug List of New Rural Cooperative Medical System from Perspective of Drug Purchasing

作　　者：程凯[1] 周仕海[2] 陈迎春[3] 丁玉峰[4] 宋大平[5] 汪早立[5] 

机构地区：[1]上海健康职业技术学院公共卫生系,上海200237 [2]华中科技大学管理学院,武汉430030 [3]华中科技大学医药卫生管理学院,武汉430030 [4]华中科技大学附属同济医院,武汉430030 [5]中华人民共和国卫生部新型农村合作医疗研究中心,北京100038

出　　处：《中国初级卫生保健》2010年第10期22-24,共3页Chinese Primary Health Care

摘　　要：通过对湖北省、重庆市4个县(市、区)的县、乡及村三级医疗机构的进药与新型农村合作医疗基本药物目录及访谈结果等相关资料的分析,发现抽样地区基层医疗机构有部分常用药品未遴选到基本药物目录中,基本药物目录内平均有51.39%的西药和69.50%的中成药,因未购进而不能在临床上使用,进一步缩窄了基本药物目录的范围,不利于基本药物目录的实施及新型农村合作医疗的开展。应进一步加快基本药物目录的建设,合理制定基本药物目录,并确保基本药物目录内药品的供应,实施强有力的监管。Comparison the varieties and category of drug between drug purchasing and Essential Drug List（EDL）of New Rural Cooperative Medical System （NCMS）of medical institutions at various levels in Hubei and ChongQing. Result shows part of common drugs of sampling area has not listed in the EDL of NCMS. Averagely 51.39% western medicine of NCMS’ EDL and 69.50% Chinese traditional medicine of NCMS’ EDL has not purchased causes not to be able in clinical use. The situation constricted the scope of EDL, and unfavorable the implementation and development of NCMS. We should further speed up the construction, formulates the EDL reasonably, and guaranteed the drugs supply, implements the powerful supervision.

关 键 词：新型农村合作医疗 基本药物目录 基本药物 

分 类 号：R197[医药卫生—卫生事业管理]